BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38391311)

  • 61. HYPORT: Phase 1 Study of 3-Week Hypofractionated Postoperative Radiation Therapy for Head and Neck Squamous Cell Carcinoma.
    Moon DH; Avkshtol V; Vo D; Ahn C; Sumer B; Day AT; Tillman B; Myers L; Truelson J; Sher DJ
    Int J Radiat Oncol Biol Phys; 2024 Jan; 118(1):157-164. PubMed ID: 37380084
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter.
    Ailianou A; Mundada P; De Perrot T; Pusztaszieri M; Poletti PA; Becker M
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):748-755. PubMed ID: 29449279
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Advances in head and neck squamous cell cancer research based on radiomics].
    Dong Y; Zhang A; Zhang J; Liu L
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Feb; 35(2):181-184. PubMed ID: 33541006
    [No Abstract]   [Full Text] [Related]  

  • 64. Quantitative ultrasound radiomics in predicting response to neoadjuvant chemotherapy in patients with locally advanced breast cancer: Results from multi-institutional study.
    DiCenzo D; Quiaoit K; Fatima K; Bhardwaj D; Sannachi L; Gangeh M; Sadeghi-Naini A; Dasgupta A; Kolios MC; Trudeau M; Gandhi S; Eisen A; Wright F; Look Hong N; Sahgal A; Stanisz G; Brezden C; Dinniwell R; Tran WT; Yang W; Curpen B; Czarnota GJ
    Cancer Med; 2020 Aug; 9(16):5798-5806. PubMed ID: 32602222
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CT Texture Analysis Potentially Predicts Local Failure in Head and Neck Squamous Cell Carcinoma Treated with Chemoradiotherapy.
    Kuno H; Qureshi MM; Chapman MN; Li B; Andreu-Arasa VC; Onoue K; Truong MT; Sakai O
    AJNR Am J Neuroradiol; 2017 Dec; 38(12):2334-2340. PubMed ID: 29025727
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A systematic review and meta-analysis of predictive and prognostic models for outcome prediction using positron emission tomography radiomics in head and neck squamous cell carcinoma patients.
    Philip MM; Welch A; McKiddie F; Nath M
    Cancer Med; 2023 Aug; 12(15):16181-16194. PubMed ID: 37353996
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessment of metastatic lymph nodes in head and neck squamous cell carcinomas using simultaneous
    Chen J; Hagiwara M; Givi B; Schmidt B; Liu C; Chen Q; Logan J; Mikheev A; Rusinek H; Kim SG
    Sci Rep; 2020 Nov; 10(1):20764. PubMed ID: 33247166
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CT Texture Analysis of Cervical Lymph Nodes on Contrast-Enhanced [
    Kuno H; Garg N; Qureshi MM; Chapman MN; Li B; Meibom SK; Truong MT; Takumi K; Sakai O
    AJNR Am J Neuroradiol; 2019 Mar; 40(3):543-550. PubMed ID: 30792253
    [TBL] [Abstract][Full Text] [Related]  

  • 69. CT radiomics nomogram for prediction of the Ki-67 index in head and neck squamous cell carcinoma.
    Zheng YM; Chen J; Zhang M; Wu ZJ; Tang GZ; Zhang Y; Dong C
    Eur Radiol; 2023 Mar; 33(3):2160-2170. PubMed ID: 36222864
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial.
    Gupta T; Sinha S; Ghosh-Laskar S; Budrukkar A; Mummudi N; Swain M; Phurailatpam R; Prabhash K; Agarwal JP
    Radiat Oncol; 2020 Sep; 15(1):218. PubMed ID: 32938468
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnosis of cervical lymph node metastases in head and neck cancer with ultrasonic measurement of lymph node volume.
    Nishio N; Fujimoto Y; Hiramatsu M; Maruo T; Tsuzuki H; Mukoyama N; Yokoi S; Wada A; Kaneko Furukawa M; Furukawa M; Sone M
    Auris Nasus Larynx; 2019 Dec; 46(6):889-895. PubMed ID: 30857763
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Predicting acute radiation induced xerostomia in head and neck Cancer using MR and CT Radiomics of parotid and submandibular glands.
    Sheikh K; Lee SH; Cheng Z; Lakshminarayanan P; Peng L; Han P; McNutt TR; Quon H; Lee J
    Radiat Oncol; 2019 Jul; 14(1):131. PubMed ID: 31358029
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Use of
    Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E
    Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718
    [No Abstract]   [Full Text] [Related]  

  • 74. Applying a nomogram based on preoperative CT to predict early recurrence of laryngeal squamous cell carcinoma after surgery.
    Yao Y; Jia C; Zhang H; Mou Y; Wang C; Han X; Yu P; Mao N; Song X
    J Xray Sci Technol; 2023; 31(3):435-452. PubMed ID: 36806538
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224).
    Saksø M; Mortensen LS; Primdahl H; Johansen J; Kallehauge J; Hansen CR; Overgaard J
    Radiother Oncol; 2020 Oct; 151():126-133. PubMed ID: 32805273
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Machine Learning-Based MRI Radiogenomics for Evaluation of Response to Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma.
    Li Z; Wang R; Wang L; Tan C; Xu J; Fang J; Xian J
    Acad Radiol; 2023 Nov; ():. PubMed ID: 37985290
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Radiomics for therapy-specific head and neck squamous cell carcinoma survival prognostication (part I).
    Bernatz S; Böth I; Ackermann J; Burck I; Mahmoudi S; Lenga L; Martin SS; Scholtz JE; Koch V; Grünewald LD; Koch I; Stöver T; Wild PJ; Winkelmann R; Vogl TJ; Dos Santos DP
    BMC Med Imaging; 2023 Jun; 23(1):71. PubMed ID: 37268876
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Intravoxel incoherent motion diffusion-weighted MRI during chemoradiation therapy to characterize and monitor treatment response in human papillomavirus head and neck squamous cell carcinoma.
    Paudyal R; Oh JH; Riaz N; Venigalla P; Li J; Hatzoglou V; Leeman J; Nunez DA; Lu Y; Deasy JO; Lee N; Shukla-Dave A
    J Magn Reson Imaging; 2017 Apr; 45(4):1013-1023. PubMed ID: 27862553
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Radiomics-based tumor phenotype determination based on medical imaging and tumor microenvironment in a preclinical setting.
    Müller J; Leger S; Zwanenburg A; Suckert T; Lühr A; Beyreuther E; von Neubeck C; Krause M; Löck S; Dietrich A; Bütof R
    Radiother Oncol; 2022 Apr; 169():96-104. PubMed ID: 35192909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.